Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 106 publications
Effects of Patiromer and Sodium Zirconium Cyclosilicate on Blood Pressure in Rats with Chronic Kidney Disease.
Journal: Journal of cardiovascular pharmacology and therapeutics
Published: February 05, 2024
VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis.
Journal: Journal of the American Society of Nephrology : JASN
Published: September 07, 2023
Association of serum bicarbonate with the development of kidney stones in patients with chronic kidney disease: a retrospective cohort study.
Journal: Clinical kidney journal
Published: August 30, 2022
Design and population of the VALOR-CKD study: a multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of veverimer in slowing progression of chronic kidney disease in patients with metabolic acidosis.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: July 25, 2022
Effect of Osteoblast-Specific Deletion of the Proton Receptor OGR1.
Journal: JBMR plus
Published: June 10, 2022
Patiromer Treatment in Patients With CKD, Hyperkalemia, and Hyperphosphatemia: A Post Hoc Analysis of 3 Clinical Trials.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: May 05, 2022
Primary Medical Care Integrated with Healthy Eating and Healthy Moving is Essential to Reduce Chronic Kidney Disease Progression.
Journal: The American journal of medicine
Published: March 29, 2022
Identification of Novel Biomarkers and Pathways for Coronary Artery Calcification in Nondiabetic Patients on Hemodialysis Using Metabolomic Profiling.
Journal: Kidney360
Published: November 01, 2021
Effects of veverimer on serum bicarbonate and physical function in women with chronic kidney disease and metabolic acidosis: a subgroup analysis from a randomised, controlled trial.
Journal: BMC nephrology
Published: September 22, 2021
Last Updated: 09/26/2026